DOJ and HHS Issue Joint Letter to Ensure That State Medicaid Programs Provide Equal Access to Hepatitis Treatment for People with Substance Use Disorder

January 25, 2024

The Justice Department announced yesterday that it and the Department of Health and Human Services (HHS) issued a joint letter to state Medicaid administrators urging them to ensure, in accordance with the Americans with Disabilities Act (ADA), that their Medicaid programs allow people who have both Hepatitis C (HCV) and substance use disorder (SUD) to access life-saving HCV medications called direct-acting antivirals (DAAs). To find out more about the ADA, visit ada.gov or call the Justice Department's toll-free ADA information line at 1-800-514-0301 or 1-833-610-1264 (TTY).